Lansoprazol Azevedos

Lansoprazole, the active ingredient in Lansoprazol Azevedos, is a proton pump inhibitor presented as an oral tablet for oral administration. It irreversibly blocks the gastric H+/K+ ATPase pump, thereby reducing stomach acid production and providing therapeutic benefit for a range of acid‑related gastrointestinal disorders in adult patients.

GNH USA supplies Lansoprazol Azevedos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance for global markets.

Lansoprazole is indicated for several gastrointestinal acid‑related conditions.

- Gastroesophageal reflux disease (GERD): reduces esophageal acid exposure and alleviates heartburn and regurgitation symptoms. - Peptic ulcer disease: promotes ulcer healing by decreasing gastric acidity. - Erosive esophagitis: facilitates mucosal repair and symptom control. - Helicobacter pylori eradication regimen: used in combination therapy to improve bacterial clearance.

Lansoprazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools often transient. - Nausea: occasional feeling of stomach upset. - Abdominal pain: cramping or discomfort. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels: muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: signs of hepatitis. - Acute interstitial nephritis: kidney inflammation.

When prescribing or dispensing Lansoprazole, consider the following precautions. - Assess renal function: dose adjustment may be needed in severe impairment. - Evaluate for osteoporosis risk: long‑term use may affect calcium absorption. - Review concomitant medications: potential for reduced efficacy of drugs requiring acidic pH. - Monitor for infection: prolonged acid suppression can increase risk of gastrointestinal infections. - Use cautiously in pregnancy: limited data, weigh benefits against potential risks. - Store at ambient temperature: keep below 25 °C, retain in original packaging and protect from moisture.

Lansoprazole can interact with other medicines, altering their effectiveness or safety.

Major Interactions (Avoid): - Antifungal agents (ketoconazole, itraconazole): reduced absorption and efficacy. - HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma concentrations. - Clopidogrel: diminished antiplatelet activity.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Methotrexate: reduced renal clearance, monitor levels. - Digoxin: altered absorption, check serum concentrations. - Iron supplements: decreased absorption, separate dosing by at least 2 hours.